Detay

Global synthetic and medicinal chemistry contract services including on a shared risk basis

BOUK20140919001

The UK arm of a global chemistry contract research organisation offers services where the local presence of medicinal chemists is backed up by the cost-effective labs in China. They are very flexible with the service model, including shared risk and publicly funded projects. They have an excellent track record of taking compounds to robust preclinical candidates. The company seeks drug discovery businesses and research groups for services and outsourcing agreements and joint ventures.

Best of both worlds: Western expertise and presence combined with cost-efficient labs in China; Very flexible models for collaboration; Customer IP security guaranteed.

The UK office represents a company that has a global presence on 4 continents. They focus exclusively on synthetic and medicinal chemistry projects. Around 100 chemists work on these, benefitting from state-of-the-art kit and the pooled experience (>100 projects) and creativity. The Chinese labs have Western trained project managers. The company boasts >95% repeat business. The customers include both Pharma and biotechnology businesses big and small. Size and stage of development matter less as the company is very flexible in terms of the nature of agreement. This includes shared risk or dual contribution/dual reward projects. The customers are guaranteed their IP security. The list of expertise includes: • Synthetic chemistry skills to generate: • Focused libraries • Reference compounds • Advanced intermediates (medium-large scale) • Final target compounds (small-medium scale) • Hit expansion libraries • Heterocyclic chemistry • Peptide and peptidomimetic chemistry (solution phase) • Nucleotide synthesis • Natural products chemistry • Isotope-labeled synthesis • Asymmetric synthetic chemistry • Resolution of enantiomers and chiral synthesis The company’s competencies cover all areas of chemistry and a broad range of target classes. The company has partners for integrated drug discovery projects. Industry or academia partners active in drug discovery and optimisation are sought. Joint venture, outsourcing or services agreements may include simple outsourcing but also projects where the parties share the risk. (New) compounds will be synthesised that serve as drug candidates, advanced intermediates, or libraries thereof.

25.9.2016

19.4.2016

17.5.2016

Keyword

03004007Pharmaceutics
03004010Special chemicals, intermediates
06001015Pharmaceutical Products / Drugs

05007002Pharmaceuticals/fine chemicals

M.74.9.0Other professional, scientific and technical activities n.e.c.

İş Birliği

Secret Know-how)

Type of partner sought: industry and academia; - Type of activity of the partner: drug discovery and optimisation; - Task to be performed by the partner sought: to provide non-confidential information on high priority projects and the type of collaboration envisaged. Joint venture, outsourcing or services agreements may include simple outsourcing but also projects where the parties share the risk. (New) compounds will be synthesised that serve as drug candidates, advanced intermediates, or libraries thereof.

SME 11-50,University,R&D Institution,SME <10,SME 51-250

Already on the market

Alan

Bio Chem Tech

Müşteri

Industry SME 50-249

English

United Kingdom

1 - 10M

Evet

Services agreement Outsourcing agreement Joint venture agreement